Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 69 Leukemia, Myeloid, Acute 32 Carcinoma, Renal Cell 27 Neoplasm Metastasis 17 Breast Neoplasms 16 Leukemia 15 Neuroblastoma 14 Kidney Neoplasms 14 Lymphoma, Non-Hodgkin 12 Ovarian Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Myelodysplastic Syndromes 10 Recurrence 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Neoplasms 8 Leukemia, Lymphocytic, Chronic, B-Cell 8 Lymphoma 7 Congenital Abnormalities 7 Colorectal Neoplasms 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Skin Neoplasms 5 Multiple Myeloma 5 Lymphoma, Mantle-Cell 5 Lymphoma, Follicular 5 Head and Neck Neoplasms 5 Fallopian Tube Neoplasms 5 Carcinoma, Hepatocellular 5 Rectal Neoplasms 4 Mesothelioma, Malignant 4 Lung Neoplasms 4

Interventions

Granulocyte-Macrophage Colony-Stimulating Factor 2 Colony-Stimulating Factors 2 nabiximols 1 fludarabine 1 camrelizumab 1 Radiofrequency Ablation 1 Interleukin-2 1 Immune Checkpoint Inhibitors 1 Cyclophosphamide 1 Adjuvants, Immunologic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Advanced Malignant Solid Tumor × Interleukin-2 × Clear all

NCT03171220 2017-06-06

NRT-01

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase 1/2 Unknown

Other solid neoplasm

Advanced Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡